Condition: COVID-19 · Sponsor: Euresist Network GEIE
The WP3 healthcare workers cohort in EuCARE is an observational multicentre study including collection of retrospective (historical) and prospective data and sample collection from health care workers with either a vaccination or a confirmed SARS-CoV-2 infection. Samples from HCW are sent to central laboratories for WP2 study were the impact of different variants in humoral and cellular immunity is to be analysed by biostatistical methods and with artificial intelligence in WP5. This analysis will focus on the impact on vaccine escape of viral variants / viral sequences as well as on any escape from any combination of natural and vaccine induced immunity. Eight countries will participate (Portugal, Italy, Germany, Lithuania, Georgia, Russia, Vietnam and Mexico).
This description comes directly from the study's public registry record.
FRANCESCA INCARDONA, DR · +393356112830 · francesca.incardona@euresist.org
Always discuss trial participation with your own doctor first.
| Heinrich Heine university | Düsseldorf, Germany | Recruiting |
| Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo | Milan, Italy | Recruiting |
| Ieo Istituto Europeo Di Oncologia | Milan, Italy | Recruiting |
| Viesoji Istaiga Vilniaus Uiversiteto Ligoninė Santaros klinikos | Vilnius, Lithuania | Recruiting |
| Hospital Juan Ghaham Casasus | Villahermosa, Mexico | Recruiting |
| Centro Hospitalar de Lisboa Ocidental | Lisbon, Portugal | Recruiting |
| Bach Mai Hospital | Hanoi, Vietnam | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05534009